Management of Atherothrombosis With Clopidogrel in High-Risk Patients - MATCH


The goal of the MATCH trial was to evaluate aspirin plus clopidogrel compared with clopidogrel alone for the prevention of vascular events and the risk of bleeding in high-risk patients with recent ischemic stroke or transient ischemic attack (TIA) and at least one additional vascular risk factor.